Professor Deborah Ashby

Publications


Journals

  • Gordon AC; Wang N; Walley KR; Ashby D; Russell JA. (19 Apr 2012). THE CARDIO-PULMONARY EFFECTS OF VASOPRESSIN COMPARED TO NOREPINEPHRINE IN SEPTIC SHOCK. Chest. DOI.
  • everitt A. (2012). IFITM3 restricts the morbidity and mortality associated with influenza. Nature.
  • Ashby D; Bird SM; Hunt I; Grant R; King T; Atkinson AC; Riani M; Gandy A; et alKvaloy JT; Caan W; Eames M; Arjas E; Boehning D; Campbell MJ; Jacques RM; Fotheringham J; Maheswaran R; Nicholl J; Chacon JE; Montanero J; Fienberg SE; Gelman A; Geskus RB; Jankowski HK; Longford NT; Louis TA; Mateu J; Mengersen K; Morton T; Playford G; Smith I; Militino AF; Ugarte MD; Porcu E; Alonso Malaver C; Zini A; Scott EM; Gemmell JC; Stein A; Woodall WH. (1 Jan 2012). Discussion on the paper by Spiegelhalter, Sherlaw-Johnson, Bardsley, Blunt, Wood and Grigg. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY. 175:25-47.
  • Pitcher A; Ashby D; Elliott P; Petersen SE. (Dec 2011). The Authors' reply. Heart. 97:1991. DOI.
  • MacCallum PK; Ashby D; Hennessy EM; Letley L; Martin J; Mt-Isa S; Vickers MR; Whyte K. (Dec 2011). Cumulative flying time and risk of venous thromboembolism. Br J Haematol. 155:613-619. DOI.
  • Cheng K; Ashby D; Smyth RL. (2011). Oral steroids for long-term use in cystic fibrosis. Cochrane Database Syst Rev. CD000407. DOI.
  • Mt-Isa S; Tzoulaki I; Callreus T; Micaleff A; Ashby D. (2011). Weighing benefit-risk of medicines: concepts and approaches. Drug Discovery Today: Technologies. In Press, Corrected Proof:---. Publisher weblink DOI.
  • Tan TM; Field BC; Minnion JS; Cuenco-Shillito J; Chambers ES; Zac-Varghese S; Brindley CJ; Mt-Isa S; et alFiorentino F; Ashby D; Ward I; Ghatei MA; Bloom SR. (Feb 2012). Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420. Br J Clin Pharmacol. 73:232-239. DOI.
  • Pitcher A; Ashby D; Elliott P; Petersen SE. (Aug 2011). Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints. Heart. 97:1286-1292. DOI.
  • Bhui KS; Dinos S; Ashby D; Nazroo J; Wessely S; White PD. (2011). Chronic fatigue syndrome in an ethnically diverse population: the influence of psychosocial adversity and physical inactivity. BMC Med. 9:26. DOI.
  • McDowell SE; Mt-Isa S; Ashby D; Ferner RE. (Dec 2010). Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Postgrad Med J. 86:734-738. DOI.
  • McDowell SE; Mt-Isa S; Ashby D; Ferner RE. (Aug 2010). Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care. 19:341-345. DOI.
  • Barkun JS; Aronson JK; Feldman LS; Maddern GJ; Strasberg SM; Balliol Collaboration; Altman DG; Barkun JS; et alBlazeby JM; Boutron IC; Campbell WB; Clavien PA; Cook JA; Ergina PL; Flum DR; Glasziou P; Marshall JC; McCulloch P; Nicholl J; Reeves BC; Seiler CM; Meakins JL; Ashby D; Black N; Bunker J; Burton M; Campbell M; Chalkidou K; Chalmers I; de Leval M; Deeks J; Grant A; Gray M; Greenhalgh R; Jenicek M; Kehoe S; Lilford R; Littlejohns P; Loke Y; Madhock R; McPherson K; Rothwell P; Summerskill B; Taggart D; Tekkis P; Thompson M; Treasure T; Trohler U; Vandenbroucke J. (26 Sep 2009). Evaluation and stages of surgical innovations. Lancet. 374:1089-1096. DOI.
  • Ergina PL; Cook JA; Blazeby JM; Boutron I; Clavien PA; Reeves BC; Seiler CM; Balliol Collaboration; et alAltman DG; Aronson JK; Barkun JS; Campbell WB; Cook JA; Feldman LS; Flum DR; Glasziou P; Maddern GJ; Marshall JC; McCulloch P; Nicholl J; Strasberg SM; Meakins JL; Ashby D; Black N; Bunker J; Burton M; Campbell M; Chalkidou K; Chalmers I; de Leval M; Deeks J; Grant A; Gray M; Greenhalgh R; Jenicek M; Kehoe S; Lilford R; Littlejohns P; Loke Y; Madhock R; McPherson K; Rothwell P; Summerskill B; Taggart D; Tekkis P; Thompson M; Treasure T; Trohler U; Vandenbroucke J. (26 Sep 2009). Challenges in evaluating surgical innovation. Lancet. 374:1097-1104. DOI.
  • McCulloch P; Altman DG; Campbell WB; Flum DR; Glasziou P; Marshall JC; Nicholl J; Balliol Collaboration; et alAronson JK; Barkun JS; Blazeby JM; Boutron IC; Campbell WB; Clavien PA; Cook JA; Ergina PL; Feldman LS; Flum DR; Maddern GJ; Nicholl J; Reeves BC; Seiler CM; Strasberg SM; Meakins JL; Ashby D; Black N; Bunker J; Burton M; Campbell M; Chalkidou K; Chalmers I; de Leval M; Deeks J; Ergina PL; Grant A; Gray M; Greenhalgh R; Jenicek M; Kehoe S; Lilford R; Littlejohns P; Loke Y; Madhock R; McPherson K; Meakins J; Rothwell P; Summerskill B; Taggart D; Tekkis P; Thompson M; Treasure T; Trohler U; Vandenbroucke J. (26 Sep 2009). No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 374:1105-1112. DOI.
  • Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; et alKnapp M; McCabe R. (2009). Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT). BMC Psychiatry. 9:61. DOI.
  • Elliott P; Chambers JC; Zhang W; Clarke R; Hopewell JC; Peden JF; Erdmann J; Braund P; et alEngert JC; Bennett D; Coin L; Ashby D; Tzoulaki I; Brown IJ; Mt-Isa S; McCarthy MI; Peltonen L; Freimer NB; Farrall M; Ruokonen A; Hamsten A; Lim N; Froguel P; Waterworth DM; Vollenweider P; Waeber G; Jarvelin M-R; Mooser V; Scott J; Hall AS; Schunkert H; Anand SS; Collins R; Samani NJ; Watkins H; Kooner JS. (1 Jul 2009). Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 302:37-48. Author weblink.
  • Dinos S; Khoshaba B; Ashby D; White PD; Nazroo J; Wessely S; Bhui KS. (Dec 2009). A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol. 38:1554-1570. DOI.
  • Ashby D. (1 Dec 2008). Establishing causality in the assessment of safety of medicines for children. ACTA PAEDIATRICA. 97:1611-1616. Author weblink DOI.
  • Carnes D; Ashby D; Parsons S; Underwood M. (Jun 2008). Chronic forearm pain presents as a transient and indistinct pain site in a community setting: results from a UK population survey. Fam Pract. 25:197-201. DOI.
  • Underwood M; Ashby D; Carnes D; Castelnuovo E; Cross P; Harding G; Hennessy E; Letley L; et alMartin J; Mt-Isa S; Parsons S; Spencer A; Vickers M; Whyte K. (May 2008). Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. Health Technol Assess. 12:iii-155.
  • Eldridge S; Ashby D; Bennett C; Wakelin M; Feder G. (19 Apr 2008). Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 336:876-880. DOI.
  • Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D. (Apr 2008). For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?. Int Psychogeriatr. 20:259-292. DOI.
  • Hughes S; Keene O; Howitt N; Roes K; Ashby D; Beltangady M; Bird SM; Burton C; et alBuyse M; Day S; van Ewijk P; Fletcher C; Grieve AP; Guinot C; Hand DJ; Hemmings R; Holt D; Hothorn L; Jagers P; Keiding N; Korhonen P; Lesaffre E; Lewis JA; Molenberghs G; Neumann N; Olsen KJ; van Osta G; Pocock S; Rockhold F; Rossi A; Senn S; Stijnen T; Vaeth M; Wiklund SJ; Wolfram J. (2 Feb 2008). European regulatory agencies should employ full time statisticians. BRITISH MEDICAL JOURNAL. 336:250-250. Author weblink DOI.
  • Underwood M; Ashby D; Cross P; Hennessy E; Letley L; Martin J; Mt-Isa S; Parsons S; et alVickers M; Whyte K; TOIB study team. (19 Jan 2008). Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ. 336:138-142. DOI.
  • Carnes D; Parsons S; Ashby D; Breen A; Foster NE; Pincus T; Vogel S; Underwood M. (Jul 2007). Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study. Rheumatology (Oxford). 46:1168-1170. DOI.
  • MacCallum P; Madhani M; Mt-Isa S; Ashby D. (Jul 2007). Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin. Pharmacoepidemiol Drug Saf. 16:786-789. DOI.
  • Lamb SE; Gates S; Underwood MR; Cooke MW; Ashby D; Szczepura A; Williams MA; Williamson EM; et alWithers EJ; Mt Isa S; Gumber A; MINT Study Team. (2007). Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disorders. BMC Musculoskelet Disord. 8:7. DOI.
  • Ashby D. (15 Nov 2006). Bayesian statistics in medicine: a 25 year review. Stat Med. 25:3589-3631. DOI.
  • Eldridge SM; Ashby D; Kerry S. (Oct 2006). Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 35:1292-1300. DOI.
  • Rudnicka AR; Mt-Isa S; Owen CG; Cook DG; Ashby D. (Oct 2006). Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 47:4254-4261. DOI.
  • Saperia J; Ashby D; Gunnell D. (17 Jun 2006). Suicidal behaviour and SSRIs: updated meta-analysis. BMJ. 332:1453. DOI.
  • Carnes D; Ashby D; Underwood M. (Jun 2006). A systematic review of pain drawing literature: should pain drawings be used for psychologic screening?. Clin J Pain. 22:449-457. DOI.
  • Coen PG; Tully J; Stuart JM; Ashby D; Viner RM; Booy R. (Apr 2006). Is it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers?. Int J Epidemiol. 35:330-336. DOI.
  • Poustie VJ; Russell JE; Watling RM; Ashby D; Smyth RL; CALICO Trial Collaborative Group. (18 Mar 2006). Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ. 332:632-636. DOI.
  • Jones AP; Remmington T; Williamson PR; Ashby D; Smyth RL. (Jul 2005). High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews. J Clin Epidemiol. 58:741-742. DOI.
  • Martinez C; Rietbrock S; Wise L; Ashby D; Chick J; Moseley J; Evans S; Gunnell D. (19 Feb 2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 330:389. DOI.
  • Gunnell D; Saperia J; Ashby D. (19 Feb 2005). Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 330:385. DOI.
  • Eldridge SM; Ashby D; Feder GS. (2005). Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials. 2:91-98.
  • Cross PL; Ashby D; Harding G; Hennessy EM; Letley L; Parsons S; Spencer AE; Underwood M; et alTOIB Study Team. (2005). TOIB Study. Are topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: a randomised controlled trial with patient preference study. [ISRCTN79353052]. BMC Musculoskelet Disord. 6:55. DOI.
  • Ashby D; Tan SB. (2005). Where's the utility in Bayesian data-monitoring of clinical trials?. Clin Trials. 2:197-205.
  • Gunnell D; Ashby D. (3 Jul 2004). Antidepressants and suicide: what is the balance of benefit and harm. BMJ. 329:34-38. DOI.
  • Preston C; Ashby D; Smyth R. (May 2004). Adjusting for publication bias: modelling the selection process. J Eval Clin Pract. 10:313-322. DOI.
  • Eldridge SM; Ashby D; Feder GS; Rudnicka AR; Ukoumunne OC. (Feb 2004). Lessons for cluster randomized trials in the twenty-first century: a systematic review of trials in primary care. Clin Trials. 1:80-90.
  • Strobl J; Enzer I; Bagust A; Haycox A; Smyth R; Ashby D; Walley T. (Sep 2003). Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry. Pharmacoepidemiol Drug Saf. 12:467-473. DOI.
  • Rudnicka AR; Ashby D; Brennan P; Meade T. (23 Jun 2003). Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect. Arch Intern Med. 163:1454-1460. DOI.
  • Golder M; Burleigh DE; Belai A; Ghali L; Ashby D; Lunniss PJ; Navsaria HA; Williams NS. (7 Jun 2003). Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. LANCET. 361:1945-1951. Author weblink DOI.
  • Elphick HE; Tan A; Ashby D; Smyth RL. (17 Aug 2002). Systematic reviews and lifelong diseases. BMJ. 325:381-384.
  • Mobbs KJ; Smyth RL; O'Hea U; Ashby D; Ritson P; Hart CA. (Jun 2002). Cytokines in severe respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 33:449-452. DOI.
  • Evans RC; Fear S; Ashby D; Hackett A; Williams E; Van Der Vliet M; Dunstan FD; Rhodes JM. (Jun 2002). Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. Gastroenterology. 122:1784-1792.
  • Smyth RL; Mobbs KJ; O'Hea U; Ashby D; Hart CA. (May 2002). Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol. 33:339-346.
  • Harrison JE; Ashby D. (2001). Orthodontic treatment for posterior crossbites. Cochrane Database Syst Rev. CD000979. DOI.
  • Ashby D; Smith AF. (15 Dec 2000). Evidence-based medicine as Bayesian decision-making. Stat Med. 19:3291-3305.
  • Poustie VJ; Watling RM; Ashby D; Smyth RL. (Aug 2000). Reliability of percentage ideal weight for height. Arch Dis Child. 83:183-184.
  • White SJ; Ashby D; Brown PJ. (2000). An introduction to statistical methods for health technology assessment. Health Technol Assess. 4:i-59.
  • Cheng K; Ashby D; Smyth R. (2000). Oral steroids for cystic fibrosis. Cochrane Database Syst Rev. CD000407. DOI.
  • Harrison JE; Ashby D. (2000). Orthodontic treatment for posterior crossbites. Cochrane Database Syst Rev. CD000979. DOI.
  • Cheng K; Smyth RL; Motley J; O'Hea U; Ashby D. (Jan 2000). Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatr Pulmonol. 29:1-7.
  • Cheng K; Ashby D; Smyth R. (2000). Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev. CD000222. DOI.
  • Poustie VJ; Watling RM; Ashby D; Smyth RL. (1 Aug 1999). Taste preference for oral calorie supplements in children with cystic fibrosis, healthy children and healthy adults. JOURNAL OF HUMAN NUTRITION AND DIETETICS. 12:301-306. Author weblink DOI.
  • Bridgman CM; Ashby D; Holloway PJ. (13 Mar 1999). An investigation of the effects on children of tooth extraction under general anaesthesia in general dental practice. Br Dent J. 186:245-247.
  • Ashby D; Smyth RL; Brown PJ. (15 Aug 1998). Statistical issues in pharmacoepidemiological case-control studies. Stat Med. 17:1839-1850.
  • Zelen M; Freedman D; Ashby D; Harrison JE; Korn EL; Baumrind S. (1 Aug 1998). Clinician preferences and the estimation of causal treatment differences - Comments and rejoinder. STATISTICAL SCIENCE. 13:228-235. Author weblink.
  • Cheng K; Preston C; Ashby D; O'Hea U; Smyth RL. (1 Aug 1998). Time to publication as full reports of abstracts of randomized controlled trials in cystic fibrosis. PEDIATRIC PULMONOLOGY. 26:101-105. Author weblink DOI.
  • Harrison JE; Ashby D. (1 Jan 1998). A systematic review of orthodontic treatment for posterior crossbites. JOURNAL OF DENTAL RESEARCH. 77:784-784. Author weblink.
  • Fletcher JN; Smyth RL; Thomas HM; Ashby D; Hart CA. (Dec 1997). Respiratory syncytial virus genotypes and disease severity among children in hospital. Arch Dis Child. 77:508-511.
  • Fayers PM; Ashby D; Parmar MK. (30 Jun 1997). Tutorial in biostatistics Bayesian data monitoring in clinical trials. Stat Med. 16:1413-1430.
  • Cheng K; Ashby D; Smyth R. (1997). Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review. J R Soc Med. 90 Suppl 31:6-12.
  • Harrison JE; Ashby D; Lennon MA. (Aug 1996). An analysis of papers published in the British and European Journals of Orthodontics. Br J Orthod. 23:203-209.
  • Abrams K; Ashby D; Errington D. (1996). A Bayesian approach to Weibull survival models--application to a cancer clinical trial. Lifetime Data Anal. 2:159-174.
  • Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA. (11 Nov 1995). Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet. 346:1247-1251.
  • Abrams K; Ashby D; Errington D. (Oct 1994). Simple Bayesian analysis in clinical trials: a tutorial. Control Clin Trials. 15:349-359.
  • Allen N; Ames D; Ashby D; Bennetts K; Tuckwell V; West C. (May 1994). A brief sensitive screening instrument for depression in late life. Age Ageing. 23:213-219.
  • Laws DE; Haslett R; Ashby D; O'Brien C; Clark D. (1994). Axial length biometry in infants with retinopathy of prematurity. Eye (Lond). 8 ( Pt 4):427-430. DOI.
  • Currie P; Ashby D; Saltissi S. (Jan 1994). Prognostic value of ambulatory ST segment monitoring compared with exercise testing at 1-3 months after acute myocardial infarction. Eur Heart J. 15:54-60.
  • Ashby D; Machin D. (Dec 1993). Stopping rules, interim analyses and data monitoring committees. Br J Cancer. 68:1047-1050.
  • Nisar M; Williams CS; Ashby D; Davies PD. (Dec 1993). Tuberculin testing in residential homes for the elderly. Thorax. 48:1257-1260.
  • Currie P; Ashby D; Saltissi S. (1 Apr 1993). Prognostic significance of transient myocardial ischemia on ambulatory monitoring after acute myocardial infarction. Am J Cardiol. 71:773-777.
  • Shields R; Jenkins SA; Baxter JN; Kingsnorth AN; Ellenbogen S; Makin CA; Gilmore I; Morris AI; et alAshby D; West CR. (Sep 1992). A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol. 16:128-137.
  • AMES D; ASHBY D; FLICKER L; SNOWDON J; WEST C; WEYERER S. (1 Jun 1992). JIM WHO - RECALL OF NATIONAL LEADERS BY ELDERLY PEOPLE IN 3 COUNTRIES. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 7:437-442. Author weblink DOI.
  • DAVIES PDO; NISAR M; WILLIAMS CSD; ASHBY D. (1 Mar 1992). RISK OF TUBERCULOSIS INFECTION IN RESIDENTIAL HOMES FOR THE ELDERLY. THORAX. 47:P228-P228. Author weblink.
  • Blettner M; Ashby D. (1992). Power calculation for cohort studies with improved estimation of expected numbers of deaths. Soz Praventivmed. 37:13-21.
  • ASHBY D; AMES D; WEST CR; MACDONALD A; GRAHAM N; MANN AH. (1 Aug 1991). PSYCHIATRIC MORBIDITY AS PREDICTOR OF MORTALITY FOR RESIDENTS OF LOCAL-AUTHORITY HOMES FOR THE ELDERLY. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 6:567-575. Author weblink DOI.
  • Errington RD; Ashby D; Gore SM; Abrams KR; Myint S; Bonnett DE; Blake SW; Saxton TE. (4 May 1991). High energy neutron treatment for pelvic cancers: study stopped because of increased mortality. BMJ. 302:1045-1051.
  • POCOCK S; ALTMAN D; ARMITAGE P; ASHBY D; BLAND M; CHILVERS C; DAWID P; EBBUTT A; et alEVANS S; FINNEY D; GARDNER M; GORE S; JONES D; LEWIS J; MACHIN D; MATTHEWS J; SPIEGELHALTER D; SUTHERLAND I; THOMPSON S. (1 Jan 1991). STATISTICS AND STATISTICIANS IN DRUG REGULATION IN THE UNITED-KINGDOM. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY. 154:413-419. Author weblink.
  • Haylen BT; Parys BT; Anyaegbunam WI; Ashby D; West CR. (May 1990). Urine flow rates in male and female urodynamic patients compared with the Liverpool nomograms. Br J Urol. 65:483-487.
  • Rugman FP; Ashby D; Davies JM. (Apr 1990). Does HLA-DR predict response to specific immunosuppressive therapy in aplastic anaemia?. Br J Haematol. 74:545-546.
  • Ashby D; West CR; Ames D. (Nov 1989). The ordered logistic regression model in psychiatry: rising prevalence of dementia in old people's homes. Stat Med. 8:1317-1326.
  • Haylen BT; Ashby D; Sutherst JR; Frazer MI; West CR. (Jul 1989). Maximum and average urine flow rates in normal male and female populations--the Liverpool nomograms. Br J Urol. 64:30-38.
  • Pocock SJ; Ashby D; Shaper AG; Walker M; Broughton PM. (Feb 1989). Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol. 42:172-179.
  • Haylen BT; Frazer MI; Sutherst JR; Ashby D. (Feb 1989). The accuracy of measurement of residual urine in women by urethral catheterisation. Br J Urol. 63:152-154.
  • Williams PS; Davenport A; McDicken I; Ashby D; Goldsmith HJ; Bone JM. (Sep 1988). Increased incidence of anti-glomerular basement membrane antibody (anti-GBM) nephritis in the Mersey Region, September 1984-October 1985. Q J Med. 68:727-733.
  • Ames D; Ashby D; Mann AH; Graham N. (Jul 1988). Psychiatric illness in elderly residents of Part III homes in one London Borough: prognosis and review. Age Ageing. 17:249-256.
  • Pocock SJ; Shaper AG; Ashby D; Delves HT; Clayton BE. (Jun 1988). The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect. 78:23-30.
  • Shaper AG; Ashby D; Pocock SJ. (May 1988). Blood pressure and hypertension in middle-aged British men. J Hypertens. 6:367-374.
  • Pocock SJ; Delves HT; Ashby D; Shaper AG; Clayton BE. (Mar 1988). Blood cadmium concentrations in the general population of British middle-aged men. Hum Toxicol. 7:95-103.
  • Pocock SJ; Ashby D; Smith MA. (Mar 1987). Lead exposure and children's intellectual performance. Int J Epidemiol. 16:57-67.
  • Ashby D; Baron DN. (Jul 1986). Harmonizing multiple choice question marks with essay marks. Med Educ. 20:321-323.
  • Broughton PM; Holder R; Ashby D. (Jul 1986). Long-term trends in biochemical data obtained from two population surveys. Ann Clin Biochem. 23 ( Pt 4):474-486.
  • ASHBY D; POCOCK SJ; SHAPER AG. (1 Jan 1986). ORDERED POLYTOMOUS REGRESSION - AN EXAMPLE RELATING SERUM BIOCHEMISTRY AND HEMATOLOGY TO ALCOHOL-CONSUMPTION. APPLIED STATISTICS-JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C. 35:289-301. Author weblink DOI.
  • Griffiths P; Baboonian C; Ashby D. (Sep 1985). The demographic characteristics of pregnant women infected with cytomegalovirus. Int J Epidemiol. 14:447-452.
  • Shaper AG; Pocock SJ; Ashby D; Walker M; Whitehead TP. (Jan 1985). Biochemical and haematological response to alcohol intake. Ann Clin Biochem. 22 ( Pt 1):50-61.
  • POCOCK SJ; ASHBY D. (1 Jan 1985). ENVIRONMENTAL LEAD AND CHILDRENS INTELLIGENCE - A REVIEW OF RECENT EPIDEMIOLOGICAL-STUDIES. STATISTICIAN. 34:31-44. Author weblink DOI.
  • Pocock SJ; Shaper AG; Ashby D; Delves T; Whitehead TP. (6 Oct 1984). Blood lead concentration, blood pressure, and renal function. Br Med J (Clin Res Ed). 289:872-874.
  • Sherlock JC; Ashby D; Delves HT; Forbes GI; Moore MR; Patterson WJ; Pocock SJ; Quinn MJ; et alRichards WN; Wilson TS. (Oct 1984). Reduction in exposure to lead from drinking water and its effect on blood lead concentrations. Hum Toxicol. 3:383-392.
  • Mann AH; Graham N; Ashby D. (Sep 1984). Psychiatric illness in residential homes for the elderly: a survey in one London borough. Age Ageing. 13:257-265.
  • Thelle DS; Shaper AG; Whitehead TP; Bullock DG; Ashby D; Patel I. (Mar 1983). Blood lipids in middle-aged British men. Br Heart J. 49:205-213.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook